Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hepatitis B
Biotech
2 biotechs shed staff, fuse to form genetic medicine company
Chroma Medicines and Nvelop Therapeutics are fusing their names and science to launch nChroma Bio, with the backing of a $75M fundraising round.
Darren Incorvaia
Dec 11, 2024 7:00am
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
Roche culls cough candidate, pivots KRAS program in Q3 update
Oct 23, 2024 6:35am
Barinthus lays off 25%, sidelines prostate cancer program
Jun 13, 2024 5:30am
GSK signs AI pact with Ochre to pinpoint source of liver disease
Jun 12, 2024 9:25am
GSK sets diversity targets, partners with DEI firm for education
May 22, 2024 11:00am